SEATTLE, July 9, 2018 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ:CTIC) and Servier today announced that the pivotal Phase III trial
Continue reading »Home ยป
mypharmacynews.com
Home ยป
SEATTLE, July 9, 2018 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ:CTIC) and Servier today announced that the pivotal Phase III trial
Continue reading »